ChemicalBook > CAS DataBase List > N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide

N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide

Product Name
N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide
CAS No.
2044702-39-6
Chemical Name
N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide
Synonyms
Osimertinib Impurity G;Osimertinib Impurity 25;AZD9291（Osimertinib） Impurity 12;N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide;2-Propenamide, N-[2-(dimethylamino)-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-
CBNumber
CB43158755
Molecular Formula
C25H26N6O2
Formula Weight
442.51
MOL File
2044702-39-6.mol
More
Less

N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide Property

Density 
1.22±0.1 g/cm3(Predicted)
pka
12.29±0.70(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide Suppliers

China 26 India 2 Global 28
More
Less

View Lastest Price from N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide manufacturers

ShenZhen H&D Pharmaceutical Technology Co., LTD
Product
AZD9291（Osimertinib） Impurity 12 2044702-39-6
Price
US $0.00-0.00/mg
Min. Order
10mg
Purity
0.98
Supply Ability
10g
Release date
2024-04-26

2044702-39-6, N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamideRelated Search:

Osimertinib Impurity M 4-fluoro-2-methoxy-3-nitrobenzenamine AZ 7550 1,4-Benzenediamine, 5-methoxy-N1,N1-dimethyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro- AZD-9291 3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide 1,2,4-Benzenetriamine, 5-methoxy-N1,N1-dimethyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]- Osimertinib mesylate 1,4-BenzenediaMine, N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]-2-nitro- Oxacillin Sodium Impurity D(EP) Oxacillin Sodium Impurity I(EP) Osimertinib Impurity N Oxacillin Sodium Impurity G(EP) AZ-5104 2-Propenamide, N-[2-[[2-(dimethyloxidoamino)ethyl]methyloxidoamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]- Osimertinib Impurity 3 Osimertinib Impurity 8 Osimertinib Impurity 2 DiHCl

  • N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide
  • Osimertinib Impurity G
  • Osimertinib Impurity 25
  • 2-Propenamide, N-[2-(dimethylamino)-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-
  • AZD9291（Osimertinib） Impurity 12
  • 2044702-39-6